BRIEF-Stemcells jumps in premarket after spinal cord injury trial results

NEW YORK Tue Feb 12, 2013 8:05am EST

NEW YORK Feb 12 (Reuters) - StemCells Inc : * Jumps 24.6 percent to $2.05 in premarket after spinal cord injury trial results

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.